These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics. Tsuruo T Cancer Treat Rep; 1983 Oct; 67(10):889-94. PubMed ID: 6354436 [TBL] [Abstract][Full Text] [Related]
13. [Vincamine effects on cultured chicken fibroblasts in vitro]. De Paermentier F; André-Balisaux G C R Seances Soc Biol Fil; 1974; 168(10-11-12):1454-6. PubMed ID: 4283112 [No Abstract] [Full Text] [Related]
14. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil. Beck WT; Cirtain MC; Look AT; Ashmun RA Cancer Res; 1986 Feb; 46(2):778-84. PubMed ID: 3455678 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of inhibition of cell proliferation by Vinca alkaloids. Jordan MA; Thrower D; Wilson L Cancer Res; 1991 Apr; 51(8):2212-22. PubMed ID: 2009540 [TBL] [Abstract][Full Text] [Related]
16. [Mitostatic agents for analyzing growth of human gliomas]. Muraoka I; Hoshino T Neurol Med Chir (Tokyo); 1979 Jun; 19(6):501-7. PubMed ID: 88681 [No Abstract] [Full Text] [Related]
17. Pharmacology, bio-analysis and pharmacokinetics of the vinca alkaloids and semi-synthetic derivatives (review). van Tellingen O; Sips JH; Beijnen JH; Bult A; Nooijen WJ Anticancer Res; 1992; 12(5):1699-715. PubMed ID: 1444238 [TBL] [Abstract][Full Text] [Related]
18. Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivity. Gan PP; Kavallaris M Cancer Res; 2008 Dec; 68(23):9817-24. PubMed ID: 19047161 [TBL] [Abstract][Full Text] [Related]